Posted by Chantel M. Contributed by US National Library of Medicine National Institutes of Health
In the study to assess the chemopreventive effects of daidzein
and its metabolites in UVB-induced skin cancer, posted in US National Library of Medicine National Institutes of Health, indicated that
7,3',4'-trihydroxyisoflavone (THIF), a major metabolite of daidzein,
effectively inhibits UVB-induced cyclooxygenase 2 (COX-2) expression
through the inhibition of NF-κB transcription activity in mouse skin
epidermal JB6 P+ cells. In contrast, daidzein had no effect on COX-2
expression levels. Data from Western blot and kinase assays showed that
7,3',4'-THIF inhibited Cot and MKK4 activity, thereby suppressing
UVB-induced phosphorylation of mitogen-activated protein kinases.
Pull-down assays indicated that 7,3',4'-THIF competed with ATP to
inhibit Cot or MKK4 activity. Topical application of 7,3',4'-THIF
clearly suppressed the incidence and multiplicity of UVB-induced tumors
in hairless mouse skin. Hairless mouse skin
results also showed that 7,3',4'-THIF inhibits Cot or MKK4 kinase
activity directly, resulting in suppressed UVB-induced COX-2 expression.
A docking study revealed that 7,3',4'-THIF, but not daidzein, easily
docked to the ATP binding site of Cot and MKK4, which is located between
the N- and C-lobes of the kinase domain. Collectively, these results
provide insight into the biological actions of 7,3',4'-THIF, a potential
skin cancer chemopreventive agent.
Total Health Breakthrough
Guide To Weight
Loss, Preventing Disease And
Premature Aging, And
Living Healthy And Longer!
For Weight Loss, healthy Living, Look Younger, Diseases Free and Longevity, please visit http://types-of-weight-loss-programs.blogspot.ca/2012/04/weight-loss-healthy-living-lokk-younger.html
For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/